Manage subscriptions

You can follow the discussion on Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors: New drug class in the treatment of Heart Failure with Reduced Ejection Fraction — DAPA-HF and EMPEROR-Reduced trials without having to leave a comment. Cool, huh? Just enter your email address in the form here below and you’re all set.